The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review

Código QR

The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review

Fengcui Sun,1 Xiufen Yang,1 Chaoqun Ma,1 Shizhao Zhang,1 Lu Yu,2 Haifei Lu,3 Guoliang Yin,1 Pengpeng Liang,1 Yanan Feng,1 Fengxia Zhang4 1Shandong University of Traditional Chinese Medicine, Jinan, 250000, People’s Republic of China; 2Tianjin University of Traditional Chinese Medicine, Tianjin, 3016...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sun F, Yang X, Ma C, Zhang S, Yu L, Lu H, Yin G, Liang P, Feng Y, Zhang F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	diosgenin hyperlipidemia serum cholesterol lipoprotein cholesterol mechanism Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/13519f308cba4135a0ad377b946e5373
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Transition Patterns of Weight Status and Their Predictive Lipid Markers Among Chinese Adults: A Longitudinal Cohort Study Using the Multistate Markov Model
por: Tang X, et al.
Publicado: (2021)

Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China
por: Chen T, et al.
Publicado: (2020)

Partículas lipoproteicas LpA-I, LpA-I: A-II y LpB en enfermedad coronaria
por: Calvo M,Carlos, et al.
Publicado: (2000)

Cálculo de la concentración de colesterol de la lipoproteína de baja densidad: análisis de regresión versus fórmula de Friedewald
por: Eblen-Zajjur,Antonio, et al.
Publicado: (2001)

Mecanismos de hipo e hiper alfalipoproteinemia en individuos adultos chilenos
por: Cuevas M,Ada, et al.
Publicado: (2004)

The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
por: Xu W, et al.
Publicado: (2020)

Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
por: Chen H, et al.
Publicado: (2019)

Scavenger Receptors and Atherosclerosis
por: RIGOTTI,ATTILIO
Publicado: (2000)

Association of Serum High-Density Lipoprotein Cholesterol with High Blood Pressures at Checkup: Results of Kanagawa Investigation of Total Checkup Data from the National Database-9 (KITCHEN-9)
por: Kei Nakajima, et al.
Publicado: (2021)

Rememorando la contribución de Goldstein y Brown al estudio del metabolismo del colesterol: a un cuarto de siglo del Premio Nobel de Medicina
por: Cortés,Víctor, et al.
Publicado: (2012)

Threshold Effects in the Relationship Between Serum Non-High-Density Lipoprotein Cholesterol and Metabolic Syndrome
por: Wang S, et al.
Publicado: (2019)

Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
por: Li X, et al.
Publicado: (2020)

El colesterol HDL: ¿un nuevo objetivo terapéutico en el manejo de las dislipidemias y la ateroesclerosis?
por: Laris E,María del Rosario, et al.
Publicado: (2005)

Efficacy of Generic Atorvastatin in a Real-World Setting
por: Manasirisuk P, et al.
Publicado: (2021)

ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
por: Vincent V, et al.
Publicado: (2019)

Evaluación de una maniobra nutricional tendiente a reducir los niveles de colesterol en pacientes portadores de enfermedad coronaria en el sistema público de salud chileno
por: Martínez O,Solange, et al.
Publicado: (2004)

La rehabilitación cardíaca como punto de partida en la prevención secundaria de la enfermedad coronaria
por: Romero C,Tomás
Publicado: (2000)

Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia via Inhibiting FXR to Induce CYP7A1
por: Lu Xiao-Rong, et al.
Publicado: (2021)

A Non-Linear Association of High-Density Lipoprotein Cholesterol with All-Cause and Cause-Specific Mortality in Diabetic Patients
por: Yan Y, et al.
Publicado: (2021)

Trends in Serum Lipid Profiles Among Korean Adolescents, 2007–2018
por: Jeong DY, et al.
Publicado: (2021)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma S, et al.
Publicado: (2019)

The individual empowerment program improves glycemic and lipid controls in admitted type 2 DM patients
por: Ampornpan Theeranut, et al.
Publicado: (2018)

El ácido nicotínico aumenta el transporte celular de colesterol de las lipoproteínas de alta densidad en pacientes con hipoalfalipoproteinemia
por: Figueroa,Catalina, et al.
Publicado: (2015)

Ethylene treatment improves diosgenin accumulation in in vitro cultures of Dioscorea zingiberensis via up-regulation of CAS and HMGR gene expression
por: Diarra,Sabake T, et al.
Publicado: (2013)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Andrey Sivkov, et al.
Publicado: (2021)

Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
por: Jarecki P, et al.
Publicado: (2019)

Frequency and characteristics of metabolic syndrome in patients with symptomatic carotid atherosclerosis
por: Maksimovic,Milos, et al.
Publicado: (2009)

Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study
por: Xie G, et al.
Publicado: (2021)

Higher Normal Levels of Triglyceride and Low and High-Density Lipoprotein Cholesterol Might Have a Protective Effect Against Activities of Daily Living Disability Within Chinese Female Centenarians: A Cross-Sectional, Complete Sample Study
por: Wang S, et al.
Publicado: (2020)

Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3
por: Hu M, et al.
Publicado: (2020)

The Association Between Hyperlipidemia and In-Hospital Outcomes in Takotsubo Cardiomyopathy
por: Li P, et al.
Publicado: (2021)

Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
por: Mba CM, et al.
Publicado: (2019)

COMPARISON OF SERUM LIPIDS LEVEL IN PATIENTS WITH BENIGN POSITIONAL VERTIGO WITH NORMAL SUBJECTS
por: A Ahmadi Ahangar, et al.
Publicado: (2008)

Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
por: Bernhard Jäger, et al.
Publicado: (2018)

Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages
por: Ling Liang, et al.
Publicado: (2021)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
por: McIntyre HD
Publicado: (2010)

Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis
por: Suksomboon N, et al.
Publicado: (2019)

High-Density Lipoprotein Cholesterol and the Risk of First Ischemic Stroke in a Chinese Hypertensive Population
por: Zhang Y, et al.
Publicado: (2021)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
por: Alberto Zambon
Publicado: (2020)